Literature DB >> 19148620

Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing.

Rafael de la Torre1, Elena Puerta, Norberto Aguirre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19148620     DOI： 10.1007/s00213-008-1455-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  12 in total

1.  Caveat emptor: editors beware.

Authors:  U D McCann; G A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

2.  Is there a case for MDMA-assisted psychotherapy in the UK?

Authors:  Ben Sessa
Journal:  J Psychopharmacol       Date:  2007-03       Impact factor: 4.153

3.  MDMA: on the translation from rodent to human dosing.

Authors:  A Richard Green; Johan Gabrielsson; Charles A Marsden; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2009-01-13       Impact factor: 4.530

4.  MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.

Authors:  José Carlos Bouso; Rick Doblin; Magí Farré; Miguel Angel Alcázar; Gregorio Gómez-Jarabo
Journal:  J Psychoactive Drugs       Date:  2008-09

5.  In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver.

Authors:  Miki Katoh; Toshiro Sawada; Yoshinori Soeno; Miki Nakajima; Chise Tateno; Katsutoshi Yoshizato; Tsuyoshi Yokoi
Journal:  J Pharm Sci       Date:  2007-02       Impact factor: 3.534

6.  Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model.

Authors:  Sharon L Miksys; Connie Cheung; Frank J Gonzalez; Rachel F Tyndale
Journal:  Drug Metab Dispos       Date:  2005-07-20       Impact factor: 3.922

7.  Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

Authors:  F X Vollenweider; A Gamma; M Liechti; T Huber
Journal:  Neuropsychopharmacology       Date:  1998-10       Impact factor: 7.853

Review 8.  Interspecies comparisons of functional genetic variations and their implications in neuropsychiatry.

Authors:  Martien J H Kas; Cigdem Gelegen; Leonard C Schalkwyk; David A Collier
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

Review 9.  Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans.

Authors:  Rafael de la Torre; Magí Farré
Journal:  Trends Pharmacol Sci       Date:  2004-10       Impact factor: 14.819

Review 10.  CYP3A4 and pregnane X receptor humanized mice.

Authors:  Frank J Gonzalez
Journal:  J Biochem Mol Toxicol       Date:  2007       Impact factor: 3.642
View more
  3 in total

Review 1.  The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives.

Authors:  J R Docherty; A R Green
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 2.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

3.  MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.

Authors:  P Sáez-Briones; A Hernández
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.